Showing results (101-110 of 3,005) with videos related to
Sort By:
Pageof 301
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Pharmacokinetic/pharmacodynamic modelling in oncological drug developmentMats O Karlsson, Therese Anehall, Lena E Friberg, et al.Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Molecular modelling of drug targets: the past, the present and the futureSvein G Dahl, Ingebrigt SylteBasic & Clinical Pharmacology & Toxicology|July 13, 2004
Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscleDejair C Nascimento, Carmen S M Serra, Antonio C OliveiraBasic & Clinical Pharmacology & Toxicology|March 18, 2004
The influence of amphotericin B and neomycin on the effect of human relaxin-2 on foetal membranes and isolated myometriumIda Vogel, Henning Grønbaek, Niels Uldbjerg, et al.Basic & Clinical Pharmacology & Toxicology|May 6, 2004
Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) ChannelsDe-Li Dong, Zhe Li, Hui-Zhen Wang, et al.Basic & Clinical Pharmacology & Toxicology|May 6, 2004
Reproductive and cytogenetic toxicity of metronidazole in male miceAbeer F el-Nahas, Ibrahim M el-AshmawyBasic & Clinical Pharmacology & Toxicology|May 6, 2004
(+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptorsMahinda Kommalage, A Urban HöglundBasic & Clinical Pharmacology & Toxicology|May 6, 2004
Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substratesTakenori Takahata, Norio Yasui-Furukori, Gen Yoshiya, et al.Basic & Clinical Pharmacology & Toxicology|January 30, 2004
Good clinical practice is now obligatory in academic clinical drug research in the European UnionAnnette Jørgensen, Karin Friis Bach, Karen FriisBasic & Clinical Pharmacology & Toxicology|January 30, 2004
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effectsWolfgang Fischer, Holger Kittner, Ralf Regenthal, et al.Pageof 301